Journal
NANOSCALE
Volume 9, Issue 4, Pages 1559-1566Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c6nr08784a
Keywords
-
Categories
Funding
- Ministry of Science and Technology [NSC 102-2113-M-007-005-MY3, NSC 104-2627-M-007-001, MOST 105-2113-M-007-021, MOST 105-2627-M-019-001]
- postdoctoral fund of the Ministry of Science and Technology of Taiwan, ROC [MOST 103-2811-M-007-039]
- National Natural Science Foundation of China [21405125]
Ask authors/readers for more resources
Clinical applications of current photodynamic therapy (PDT) agents are often restricted to be activated only by UV and visible light, which have very poor tissue penetration depths. In this study, a new near infrared (NIR)-absorbing nanoagent based on graphene oxide decorated with iron hydroxide/oxide (GO-FeOxH) was developed for light-activated nanomaterial-mediated PDT. This nanocomposite, GO-FeOxH was prepared via the one-step electrooxidation of iron nails in an aqueous GO solution. The as-prepared GO-FeOxH showed a much higher reactive oxygen species (ROS) activity under NIR light irradiation than GO. Through a variety of spectroscopic analyses, the mechanism involved in the enhancement of ROS activity of GO by FeOxH was systematically investigated. We observed that NIR light irradiation promotes electron transfer from GO to the Fe(III) of FeOxH and accelerates their reaction with O-2, forming superoxide anion radicals, which then undergo a disproportionation reaction to produce H2O2. H2O2 then reacts with Fe(II) in FeOxH to mediate Fenton reactions, producing amplified hydroxyl radicals. Using in vitro studies, we demonstrated that GO-FeOxH can be used as a NIR activatable PDT nanoagent, providing efficient cancer therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available